Valsartan-d3 (CAS 1331908-02-1)
QUICK LINKS
Valsartan-d3 is a deuterium-labeled version of valsartan, where three hydrogen atoms are replaced by deuterium, a stable isotope of hydrogen. This compound is utilized in analytical chemistry research, particularly in the study of chemical metabolism and kinetics. The incorporation of deuterium atoms does not significantly alter the pharmacological properties of the compound but provides a distinct mass that can be detected and measured using mass spectrometry. This allows for the tracking of valsartan-d3 in biological systems and the differentiation from endogenous substances or metabolites. In studies focusing on chemical interactions, valsartan-d3 can be used as an internal standard to provide accurate quantification of valsartan levels in complex biological matrices. Additionally, it is utilized in environmental science research to monitor the presence and persistence of valsartan in water systems.
Valsartan-d3 (CAS 1331908-02-1) References
- Simple RP-HPLC method for determination of triple drug combination of valsartan, amlodipine and hydrochlorothiazide in human plasma. | Sharma, RN. and Pancholi, SS. 2012. Acta Pharm. 62: 45-58. PMID: 22472448
- Occurrence of cardiovascular drugs in the sewage-impacted Vistula River and in tap water in the Warsaw region (Poland). | Giebułtowicz, J., et al. 2016. Environ Sci Pollut Res Int. 23: 24337-24349. PMID: 27655616
- Quantification of 21 antihypertensive drugs in serum using UHPLC-MS/MS. | Gundersen, POM., et al. 2018. J Chromatogr B Analyt Technol Biomed Life Sci. 1089: 84-93. PMID: 29783197
- Suspect and untargeted screening of bisphenol S metabolites produced by in vitro human liver metabolism. | Gys, C., et al. 2018. Toxicol Lett. 295: 115-123. PMID: 29908846
- Ozonation of valsartan: Structural elucidation and environmental properties of transformation products. | Diehle, M., et al. 2019. Chemosphere. 216: 437-448. PMID: 30384314
- Trends and disparities in urinary BPA concentrations among U.S. emerging adults. | van Woerden, I., et al. 2019. Environ Res. 176: 108515. PMID: 31195292
- Pharmacokinetic and Safety Profiles of a Fixed-Dose Combination of Amlodipine, Valsartan, and Atorvastatin: A 3-Period Replicate Crossover Study. | Kim, S., et al. 2020. Clin Pharmacol Drug Dev. 9: 386-394. PMID: 31373174
- Comparison of high resolution mrm and sequential window acquisition of all theoretical fragment-ion acquisition modes for the quantitation of 48 wastewater-borne pollutants in lettuce. | Montemurro, N., et al. 2020. J Chromatogr A. 1631: 461566. PMID: 33002708
- A multi-residue analytical method for extraction and analysis of pharmaceuticals and other selected emerging contaminants in sewage sludge. | Riva, F., et al. 2021. Anal Methods. 13: 526-535. PMID: 33447838
- Determination of Pharmaceuticals, Heavy Metals, and Oxysterols in Fish Muscle. | Bobrowska-Korczak, B., et al. 2021. Molecules. 26: PMID: 33668999
- Ecotoxicological risk assessment of wastewater irrigation on soil microorganisms: Fate and impact of wastewater-borne micropollutants in lettuce-soil system. | Gallego, S., et al. 2021. Ecotoxicol Environ Saf. 223: 112595. PMID: 34390984
- Comparative Pharmacokinetics Between a Fixed-Dose Combination of Pitavastatin/Valsartan 4/160 mg and the Corresponding Individual Components Through a Partial Replicated Crossover Design in Healthy Male Subjects. | Na, JY., et al. 2022. Clin Pharmacol Drug Dev. 11: 615-622. PMID: 34997835
- Efficient Evaluation of In Vivo Performance in Human for Generic Formulation by Novel Dissolution-Absorption Prediction (DAP) Workflow. | Onishi, M., et al. 2022. Pharm Res. 39: 2203-2216. PMID: 35836039
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Valsartan-d3, 1 mg | sc-220363 | 1 mg | $394.00 |